XML 44 R32.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Fair value measurement (Tables)
3 Months Ended
Mar. 31, 2024
Fair Value Disclosures [Abstract]  
Financial assets and liabilities carried at fair value measured on recurring basis
The following tables provide information regarding our financial assets and liabilities measured at fair value on a recurring basis as of March 31, 2024 and December 31, 2023:
 
Total carrying
 value at
 March 31, 2024
Quoted prices in active
markets (Level 1)
Significant other
observable
Inputs (Level 2)
Significant
unobservable
Inputs (Level 3)
Investments in marketable securities$5,854 $5,854 $— $— 
Derivative assets22,860 — 22,860 — 
Derivative liabilities34,412 — 34,412 — 
Contingent consideration liabilities40,279 — — 40,279 
 Total carrying
value at December 31, 2023
Quoted prices in active
markets (Level 1)
Significant other
observable
Inputs (Level 2)
Significant
unobservable
Inputs (Level 3)
Investments in marketable securities$5,306 $5,306 $— $— 
Derivative assets19,449 — 19,449 — 
Derivative liabilities35,303 — 35,303 — 
Contingent consideration liabilities39,486 — — 39,486 
Schedule of Valuation Techniques
The table below provides additional information regarding the valuation technique and inputs used in determining the fair value of our significant contingent consideration liabilities.
Contingent Consideration LiabilityValuation TechniqueUnobservable Input
Range (Weighted average)
Revenue-based
Monte Carlo simulationRevenue volatility
19.1% - 31.2% (22.3%)
Risk free rateCost of debt structure
Projected year of payment
2025 - 2026
Reconciliation of Changes in Level 3 Financial Liabilities Measured at Fair Value on Recurring Basis
The following table provides information regarding changes in our contingent consideration liabilities for the three months ended March 31, 2024:
Contingent consideration
Balance – December 31, 2023
$39,486 
Payments(72)
Revaluations865 
Balance – March 31, 2024
$40,279